The Case For/Against Revascularization For Secondary Prevention. Michael DeBaun MD, MPH

Patient case discussion (case #1)Подробнее

Impact of Hypertrophic Obstructive Cardiomyopathy on Sepsis OutcomesПодробнее

Anti-CD20 therapies and COVID-19 | MS AcademyПодробнее

Key recurrent mutations in MDSПодробнее

Transplant VOD: key issuesПодробнее

Advances in Hematology: Robert S. Negrin, MDПодробнее

Impact of Hypertrophic Obstructive Cardiomyopathy on Sepsis OutcomesПодробнее

The current standard of care for patients with lower-risk MDSПодробнее

Case of Primary Hepatic Neuroendocrine Tumor Resulting in Disseminated Intravascular CoagulationПодробнее

Battling Drug ResistanceПодробнее

Novel agents for MDS on the basis of understanding disease biologyПодробнее

How to deal with vascular anomaliesПодробнее

The Inflammatory Basis of Artherosclerosis: The Case of Rheumatoid ArthritisПодробнее

The role of transplantation in MDSПодробнее

How Biosimilars Can Reduce Healthcare CostsПодробнее

UNCAGE Bifurcations - Make the Complex Simple - A case-based discussionПодробнее

How to improve transplant outcomes in MDS?Подробнее

Frontiers in Medicine: Community - Andra Blomkalns, MDПодробнее